Orlistat Related Compound D

Orlistat Related Compound D, also known as (1S, 2S)-1-[(3, 5-dichloro-4-methylphenyl)hexanoyl]-2-[(2-oxooxazolidin-3-yl)methyl]dodecyl ester, is a chemical compound that is closely related to the pharmaceutical drug Orlistat. Orlistat is a medication used to treat obesity by inhibiting the absorption of dietary fats in the body. Orlistat Related Compound D is a synthetic intermediate used in the production of Orlistat. Orlistat Related Compound D is used in the laboratory for research purposes and is not approved for human use. It has been found to be a potent inhibitor of pancreatic lipase, the enzyme responsible for breaking down dietary fats. This property makes it a valuable tool for studying the mechanisms of fat absorption and metabolism in the body. Chemically, Orlistat Related Compound D is a complex molecule with a molecular weight of 779.06 g/mol. It has a melting point of 55-60°C and a solubility of 0.01 mg/mL in water. Its chemical structure consists of a long hydrocarbon chain attached to an oxazolidinone ring, which is in turn attached to a dichloromethylphenyl group. In conclusion, Orlistat Related Compound D is an important chemical compound in the production of Orlistat and also a valuable tool in research. Its potent inhibition of pancreatic lipase makes it useful in studying fat metabolism, and its chemical structure provides insights into the design of new drugs for the treatment of obesity and related disorders.